Impact of RxPONDER and monarchE on the Surgical Management of the Axilla in Patients With Breast Cancer
Author:
Affiliation:
1. Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA
2. Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA
3. Division of Cancer Medicine, Dana-Farber Cancer Institute, Boston, MA
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.00173
Reference17 articles.
1. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
2. Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
3. Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
4. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
5. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Optimal management of breast cancer with physical exam negative/radiological abnormal axilla;Scientific Reports;2024-09-03
2. Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial;The Lancet Oncology;2024-09
3. Electronic Health Record–Based Nudge Intervention and Axillary Surgery in Older Women With Breast Cancer;JAMA Surgery;2024-07-17
4. Operative Therapie des Mammakarzinoms: „One size does not fit all“;Die Gynäkologie;2024-05
5. Comparison of long-term outcome between clinically high risk lobular versus ductal breast cancer: a propensity score matched study;eClinicalMedicine;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3